In conjunction with its 51 percent stake in Immuneering, Teva will have the right of first refusal in projects related to CNS disorder treatments.
The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.
Access to the full genome map is expected to boost efforts to develop more resistant, higher-yield varieties of wheat.
The method detects somatic copy number alterations in whole-exome datasets without requiring input from users and irrespective of sequencing platform.
The software offers data processing and management capabilities that are designed to support more automated and efficient whole-exome sequencing-based testing.
In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.
A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.
Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.
Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."